Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Peripheral Blood CAR T-Cell Level Using a Clia-Validated Assay Is Prognostic for Treatment Response and Icans in Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3001.

https://doi.org/10.1182/blood-2024-208300

Published: 2024

Journal Articles

Clinical Outcomes and Patterns of Care Among Patients with Newly Diagnosed Hodgkin Lymphoma in a Safety-Net Health System

Jun Yang Jiang, Trung Minh Nguyen, Jason Lu, Danielle Guffey, Rockbum Kim, Abiodun Oluyomi, Omar Rosales, Raka Bandyo, Courtney Nicole Miller-Chism, Mark M. Udden, Martha P. Mims, Tareq Abuasab, Akiva Diamond, Purnima Sravanti Teegavarapu, Chijioke Nze, Christopher R. Flowers, Ang Li

Blood (2024) 144 (Supplement 1): 3727.

https://doi.org/10.1182/blood-2024-203368

Published: 2024

Journal Articles

Use of Molecular Immune Signatures for Frontline Treatment Selection in Patients with Advanced Stage Follicular Lymphoma

Tony Z. Zhuang, Lei Feng, Dai Chihara, Chijioke Nze, Amy A. Ayers, Mansoor Noorani, James D. Ayres, Daniela E. Duenas, Kumudha Balakrishnan, Ekaterina Nesterenko, Mark Meerson, Ksenia Zornikova, Krystle Nomie, Nikita Kotlov, Nathan Fowler, Maria Alma Rodriguez, Sattva S. Neelapu, Christopher R. Flowers, Paolo Strati

Blood (2024) 144 (Supplement 1): 2982.

https://doi.org/10.1182/blood-2024-202654

Published: 2024

Journal Articles

Genomic and Spatial Proteomic Characterization of the Microenvironment of Diffuse Large B-Cell Lymphoma in African American Patients

Michelle J. Lee, Kumudha Balakrishnan, Arman Petrosyants, Daniil Wiebe, Chijioke Nze, Neha Akkad, Amy Ayers, James D. Ayres, Timothy J. McDonnell, Pavel Zemskiy, Kiril Kriukov, Alexander Nesmelov, Ksenia Zornikova, Krystle Nomie, Alexander Sarachakov, Nikita Kotlov, Ankur Singh, Jean L. Koff, Christopher R. Flowers

Blood (2024) 144 (Supplement 1): 4348.

https://doi.org/10.1182/blood-2024-210184

Published: 2024

Journal Articles

Impact of Pre-Existing Mental Health Disorders (MHD) on CAR T-Cell Therapy Outcomes in Patients with Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 4508.

https://doi.org/10.1182/blood-2024-198053

Published: 2024

Journal Articles

Factors Influencing Clinical Trial Participation Among Patients with Non-Hodgkin Lymphoma Receiving Care in a Safety Net Hospital

Alexis Romero, Sophia Nguyen, Amy A. Ayers, Rebecca Yzquierdo, Lorna McNeill, Hilary Ma, Michael Overman, James R. Cerhan, Christopher R. Flowers, Chijioke Nze

Blood (2024) 144 (Supplement 1): 3746.

https://doi.org/10.1182/blood-2024-211976

Published: 2024

Journal Articles

Perceptions of Clinical Trials and Factors Influencing Trial Participation Among Hispanic Patients with Non-Hodgkin Lymphoma

Alexis Romero, Sophia Nguyen, Amy A. Ayers, Minxing Chen, Clark R. Andersen, Rebecca Yzquierdo, Adiya Rahman, Lauren Johnson, Tiffany Vickers, Zeinab Wafi, Lorna McNeill, James R. Cerhan, Christopher R. Flowers, Chijioke Nze

Blood (2024) 144 (Supplement 1): 3733.

https://doi.org/10.1182/blood-2024-211657

Published: 2024

Journal Articles

Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Kunhwa Kim, Dai Chihara, Luis E. Fayad, Sattva S. Neelapu, Sairah Ahmed, Frederick Hagemeister, Chijioke Nze, Swaminathan P Iyer, Preetesh Jain, Michael Wang, Paolo Strati, Fateeha Furqan, Ayushi Chauhan, Michael R. Green, Christopher R. Flowers, Jason R. Westin

Blood (2024) 144 (Supplement 1): 4511.1.

https://doi.org/10.1182/blood-2024-205196

Published: 2024

Journal Articles

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Hun Ju Lee, Gregory Ravizzini, Eslam Aboismail, Jenna Wixom, Jared Henderson, Luis E. Fayad, Sairah Ahmed, Ranjit Nair, Jason R. Westin, Swaminathan P Iyer, Chijioke Nze, Ajlan Al Zaki, Francisco Vega, Michael Wang, Christopher R. Flowers, Luis Malpica

Blood (2024) 144 (Supplement 1): 1674.3.

https://doi.org/10.1182/blood-2024-212005

Published: 2024

Journal Articles

Retreatment with R-CHOP-like Therapy Is Active with Durable Responses in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

Eduardo Edelman Saul, Bryan Valcarcel, Amy A. Ayers, Mansoor Noorani, Dai Chihara, Fateeha Furqan, Sairah Ahmed, Swaminathan P Iyer, Sattva S. Neelapu, Luis E. Fayad, F. B. Hagemeister, Chijioke Nze, Preetesh Jain, Michael Wang, Paolo Strati, Ayushi Chauhan, Francisco Vega, Christopher R. Flowers, Jason R. Westin

Blood (2024) 144 (Supplement 1): 4454.

https://doi.org/10.1182/blood-2024-211247

Published: 2024

Journal Articles

T-Cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis Has Worse Survival When Compared to T-Cell Lymphoma: A Retrospective Analysis from a Single Tertiary Center

Blood (2024) 144 (Supplement 1): 6420.

https://doi.org/10.1182/blood-2024-211482

Published: 2024

Journal Articles

Identifying the Barriers of Clinical Trial Access after CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma

Kunhwa Kim, Amy Ayers, Sairah Ahmed, Linda Claret, Paolo Strati, Ranjit Nair, Chijioke Nze, Jeremy Ramdial, Janet Torres, Elizabeth J. Shpall, Luis E. Fayad, Loretta Nastoupil, Jason R. Westin, Christopher R. Flowers, Sattva S. Neelapu, Dai Chihara

Blood (2024) 144 (Supplement 1): 5121.

https://doi.org/10.1182/blood-2024-211023

Published: 2024

Journal Articles

Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System

Jun Yang Jiang, Chijioke Nze, Danielle Guffey, Rockbum Kim, Abiodun O. Ouyomi, Omar Rosales, Raka Bandyo, Akiva Diamond, Gustavo A. Rivero, Courtney Nicole Miller-Chism, Mark M. Udden, Martha P. Mims, Christopher R. Flowers, Ang Li, Purnima Sravanti Teegavarapu

Blood (2023) 142 (Supplement 1): 5140.

https://doi.org/10.1182/blood-2023-173927

Published: 2023

Journal Articles

Perceptions and Practices of Clinical Trial Enrollment Among Patients with Non-Hodgkin Lymphoma, Caregivers, and Providers

Tisheeka Graham, Tariqa Ackbarali, Chijioke Nze, Ashley Bryant, Adolfo Diaz Duque, Christopher R. Flowers

Blood (2023) 142 (Supplement 1): 2388.

https://doi.org/10.1182/blood-2023-180181

Published: 2023

Journal Articles

Outcomes in Patients with Relapsed Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with CAR-T Cell Therapies or Salvage Chemotherapy - a Single-Institution Experience

Blood (2023) 142 (Supplement 1): 6327.

https://doi.org/10.1182/blood-2023-191096

Published: 2023

Journal Articles

Impact of Patient Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation Patterns for Non-Hodgkin Lymphoma at a Major Academic Institution

Chijioke Nze, Clark R Andersen, Amy Ayers, Jason Westin, Michael L. Wang, Swaminathan P. Iyer, Sairah Ahmed, Chelsea C. Pinnix, Francisco Vega, Lorna McNeil, Lynne Nguyen, Loretta J. Nastoupil, Christopher R. Flowers

Blood (2022) 140 (Supplement 1): 7943–7945.

https://doi.org/10.1182/blood-2022-165451

Published: 2022

Journal Articles

Sudden Death in Sickle Cell Disease: An Assessment of Risk Factors

Chijioke Nze, MD, Brooke M Fortin, BA, BS, Revital Freedman, PhD, Maneka Puligandla, MS, Donna S Neuberg, ScD, Elyse Mandell, ANP, Maureen Achebe, MD MPH

Blood (2018) 132 (Supplement 1): 4929.

https://doi.org/10.1182/blood-2018-99-119860

Published: 2018

NARROW

Peripheral Blood CAR T-Cell Level Using a Clia-Validated Assay Is Prognostic for Treatment Response and Icans in Large B-Cell Lymphoma

Clinical Outcomes and Patterns of Care Among Patients with Newly Diagnosed Hodgkin Lymphoma in a Safety-Net Health System

Use of Molecular Immune Signatures for Frontline Treatment Selection in Patients with Advanced Stage Follicular Lymphoma

Genomic and Spatial Proteomic Characterization of the Microenvironment of Diffuse Large B-Cell Lymphoma in African American Patients

Impact of Pre-Existing Mental Health Disorders (MHD) on CAR T-Cell Therapy Outcomes in Patients with Large B-Cell Lymphoma

Factors Influencing Clinical Trial Participation Among Patients with Non-Hodgkin Lymphoma Receiving Care in a Safety Net Hospital

Perceptions of Clinical Trials and Factors Influencing Trial Participation Among Hispanic Patients with Non-Hodgkin Lymphoma

Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Retreatment with R-CHOP-like Therapy Is Active with Durable Responses in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

T-Cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis Has Worse Survival When Compared to T-Cell Lymphoma: A Retrospective Analysis from a Single Tertiary Center

Identifying the Barriers of Clinical Trial Access after CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma

Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System

Perceptions and Practices of Clinical Trial Enrollment Among Patients with Non-Hodgkin Lymphoma, Caregivers, and Providers

Outcomes in Patients with Relapsed Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with CAR-T Cell Therapies or Salvage Chemotherapy - a Single-Institution Experience

Impact of Patient Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation Patterns for Non-Hodgkin Lymphoma at a Major Academic Institution

Sudden Death in Sickle Cell Disease: An Assessment of Risk Factors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only